Notes

Translation and version in the EORTC QLQ-LC 30 for usage inside Chinese sufferers using carcinoma of the lung.
When neighboring rings are orthogonal to each other, the transmission through both π- and σ-systems is effectively suppressed. Alternatively, breaking conjugation in a single phenyl ring by saturating two carbons atoms with two methyl substituents on each carbon, results in suppressed π- and σ-transport independent of dihedral angle. These two strategies demonstrate that methyl-substituted oligophenyls are promising candidates for the development of molecular dielectric materials.Although computational prediction of new ice phases is a niche field in water science, the scientific subject itself is representative of two important areas in physical chemistry, namely, statistical thermodynamics and molecular simulations. The prediction of a variety of novel ice phases has also attracted general public interest since the 1980s. In particular, the prediction of low-dimensional ice phases has gained momentum since the confirmation of a number of low-dimensional "computer ice" phases in the laboratory over the past decade. In this Perspective, the research advancements in computational prediction of novel ice phases over the past few years are reviewed. Particular attention is placed on new ice phases whose physical properties or dimensional structures are distinctly different from conventional bulk ices. Specific topics include the (i) formation of superionic ices, (ii) electrofreezing of water under high pressure and in a high external electric field, (iii) prediction of low-density porous ice at strongly negative pressure, (iv) ab initio computational study of two-dimensional (2D) ice under nanoscale confinement, and (v) 2D ices formed on a solid surface near ambient temperature without nanoscale confinement. Clearly, the formation of most of these novel ice phases demands certain extreme conditions. Ongoing challenges and new opportunities for predicting new ice phases from either classical molecular dynamics simulation or high-level ab initio computation are discussed.Colloidal quantum dots (QDs) suffer from pervasive photoluminescence intermittency that frustrates applications and correlates with irreversible photodegradation. In single-QD spectroscopies, blinking manifests as sporadic switching between ON and OFF states without a characteristic time scale, and the longstanding search for mechanisms has been recently accelerated by techniques to controllably modulate the QD environment. selleck chemicals Here, we develop an all-optical modulation scheme and demonstrate that sub-bandgap light tuned to the stimulated emission transition perturbs the blinking statistics of individual CdSe/ZnS core/shell QDs. Resonant optical modulation progressively suppresses long-duration ON events, quantified by a power-law slope that is more negative on average (ΔαON = 0.46 ± 0.09), while OFF distributions and truncation times are unaffected. This characteristic effect is robust to choices in background subtraction and statistical analysis but supports mechanistic descriptions beyond first-order kinetics. This demonstration of all-optical perturbation of QD blinking dynamics provides an experimental avenue to disentangle the complex photophysics of photoluminescence intermittency.Brain microvascular endothelial cells derived from induced pluripotent stem cells (dhBMECs) are a scalable and reproducible resource for studies of the human blood-brain barrier, including mechanisms and strategies for drug delivery. Confluent monolayers of dhBMECs recapitulate key in vivo functions including tight junctions to limit paracellular permeability and efflux and nutrient transport to regulate transcellular permeability. Techniques for cryopreservation of dhBMECs have been reported; however, functional validation studies after long-term cryopreservation have not been extensively performed. Here, we characterize dhBMECs after 1 year of cryopreservation using selective purification on extracellular matrix-treated surfaces and ROCK inhibition. One-year cryopreserved dhBMECs maintain functionality of tight junctions, efflux pumps, and nutrient transporters with stable protein localization and gene expression. Cryopreservation is associated with a decrease in the yield of adherent cells and unique responses to cell stress, resulting in altered paracellular permeability of Lucifer yellow. Additionally, cryopreserved dhBMECs reliably form functional three-dimensional microvessels independent of cryopreservation length, with permeabilities lower than non-cryopreserved two-dimensional models. Long-term cryopreservation of dhBMECs offers key advantages including increased scalability, reduced batch-to-batch effects, the ability to conduct well-controlled follow up studies, and support of multisite collaboration from the same cell stock, all while maintaining phenotype for screening pharmaceutical agents.Targeted alpha-particle therapy (TAT) might be a relevant therapeutic strategy to circumvent resistance to conventional therapies in the case of HER2-positive metastatic cancer. Single-domain antibody fragments (sdAb) are promising vehicles for TAT because of their excellent in vivo properties, high target affinity, and fast clearance kinetics. This study combines the cytotoxic α-particle emitter bismuth-213 (213Bi) and HER2-targeting sdAbs. The in vitro specificity, affinity, and cytotoxic potency of the radiolabeled complex were analyzed on HER2pos cells. Its in vivo biodistribution through serial dissections and via Cherenkov and micro-single-photon emission computed tomography (CT)/CT imaging was evaluated. Finally, the therapeutic efficacy and potential associated toxicity of [213Bi]Bi-DTPA-2Rs15d were evaluated in a HER2pos tumor model that manifests peritoneal metastasis. In vitro, [213Bi]Bi-DTPA-2Rs15d bound HER2pos cells in a HER2-specific way. In mice, high tumor uptake was reached already 15 min after injection, and extremely low uptake values were observed in normal tissues. Co-infusion of gelofusine resulted in a 2-fold reduction in kidney uptake. Administration of [213Bi]Bi-DTPA-2Rs15d alone and in combination with trastuzumab resulted in a significant increase in median survival. We describe for the very first time the successful labeling of an HER2-sdAb with the α-emitter 213Bi, and after intravenous administration, revealing high in vivo stability and specific accumulation in target tissue and resulting in an increased median survival of these mice especially in combination with trastuzumab. These results indicate the potential of [213Bi]Bi-DTPA-sdAb as a new radioconjugate for TAT, alone and as an add-on to trastuzumab for the treatment of HER2pos metastatic cancer.
Homepage: https://www.selleckchem.com/products/gbd-9.html